Dave Hickey serves as executive vice president and president of the Life Sciences segment. In this role, he oversees the global operational, commercial and financial performance of the businesses that comprise the Life Sciences segment that span along the continuum of discovery, translational, diagnostics and therapy selection, including Biosciences and Integrated Diagnostic Solutions. He also leads the Latin America region for the company and is a member of the BD Executive Leadership Team.
Hickey brings more than 30 years of experience in medical technology. He joined BD in 2014 as vice president and general manager for the Clinical Microbiology business. In 2016, he was promoted to president of the Diagnostics Systems business, and in 2019, to worldwide president of the newly formed Integrated Diagnostic Solutions unit, which brought together the strengths of the Diagnostic Systems and Preanalytical Systems businesses.
Under Hickey’s leadership, IDS became instrumental in the global fight against SARS-CoV-2 (COVID-19), overseeing the development, launch, manufacturing and distribution of critical molecular and rapid point-of-care tests as well as critical swabs and viral transport systems. Today, he leads a team of more than 18,000 associates united in a vision to shape the future of healthcare through the translation and delivery of innovative technologies to advance life sciences medical research and create impactful diagnostics solutions for customers and the patients they serve.
Prior to BD, Hickey spent 22 years with Siemens Healthcare Diagnostics in multiple positions of increasing responsibility, including his last four years as CEO of its Central Laboratory Business Unit.
Hickey is an active participant on the boards of directors for AdvaMedDx, Analytical, Life Science & Diagnostics Association (ALDA), Greater Baltimore Committee, Johns Hopkins Bloomberg School of Public Health, and the University of Maryland, Baltimore (UMB) Health Sciences Research Park.
Hickey earned his Medical Laboratory Sciences degree in Clinical Biochemistry from the University of Manchester in the UK.